Sidney Farber

Also found in: Medical, Wikipedia.

Farber, Sidney

(1903–73) oncologist; born in Buffalo, N.Y. He began as a pathologist at the Children's Hospital in Boston and taught at Harvard (1929). His life's work revolved around cancer therapy, research, and patient care. In 1947 he founded the Children's Cancer Research Foundation (now, in his honor, the Dana-Farber Cancer Center) and achieved the first remissions in childhood leukemia by using chemotherapy.
References in periodicals archive ?
After studying for a degree at Churchill College, Cambridge, and a DPhil at Lincoln College, Oxford, he trained at the Imperial Cancer Research Fund in London and the Sidney Farber (now Dana-Farber) Cancer Institute in Boston, US, before returning to the UK to work at the ICR.
Part One emphasized the historical roles of the Harvard pathologist Sidney Farber and the philanthropist Mary Woodard Lasker, to both of whom I shall return.
Sidney Farber -- widely acclaimed as the father of chemotherapy -- emerges as a central character in the book.
Mukherjee also highlights many of the unsung heroes in the cancer fight, including Sidney Farber, the pediatric pathologist who invented modern chemotherapy, and Mary Lasker, the New England socialite who lobbied tirelessly for cancer funding.
Scientific optimism after the Second World War led a leading American oncologist, Sidney Farber, to talk in 1962 of the underlying "singularity" of cancer, and to postulate a "universal cure",.
18 /PRNewswire/ -- Stop & Shop today announced it received the 2010 Sidney Farber Medical Research Award, Dana-Farber Cancer Institute's highest accolade, for its 20-year partnership, that has raised more than $50 million for Dana-Farber and the Jimmy Fund, through Stop & Shop's annual Triple Winner Game.
Sidney Farber, "Unexpected Death in Early Life," New England Journal of Medicine 219 (1938): especially 839-840, and Sidney Farber, "Studies of Sudden Death in Infants," National Safety Council Transactions (1952): Part 13, pp.
Sidney Farber, a pathologist at Boston Children's Hospital, was so distressed doing autopsies on these children that he moved into the clinic and, against the advice of more conservative colleagues, began treating children with aminopterin, a highly toxic drug that starved their cancerous white blood cells of critical nutrients.
at the University of Washington, and completed a fellowship in pediatric immunology at the Children's Hospital Medical Center and received additional training in pediatric oncology at the Sidney Farber Cancer Institute.